208 related articles for article (PubMed ID: 23472935)
1. Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
Varagic Z; Ramerstorfer J; Huang S; Rallapalli S; Sarto-Jackson I; Cook J; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):384-99. PubMed ID: 23472935
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
Varagic Z; Wimmer L; Schnürch M; Mihovilovic MD; Huang S; Rallapalli S; Cook JM; Mirheydari P; Ecker GF; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):371-83. PubMed ID: 23472852
[TBL] [Abstract][Full Text] [Related]
3. Towards functional selectivity for α6β3γ2 GABA
Treven M; Siebert DCB; Holzinger R; Bampali K; Fabjan J; Varagic Z; Wimmer L; Steudle F; Scholze P; Schnürch M; Mihovilovic MD; Ernst M
Br J Pharmacol; 2018 Feb; 175(3):419-428. PubMed ID: 29127702
[TBL] [Abstract][Full Text] [Related]
4. Molecular mode of action of CGS 9895 at α1 β2 γ2 GABAA receptors.
Maldifassi MC; Baur R; Sigel E
J Neurochem; 2016 Sep; 138(5):722-30. PubMed ID: 27319298
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of GABA(A) receptor function by aryl pyrazoles.
Mascia MP; Ledda G; Orrù A; Marongiu A; Loriga G; Maciocco E; Biggio G; Ruiu S
Eur J Pharmacol; 2014 Jun; 733():1-6. PubMed ID: 24704372
[TBL] [Abstract][Full Text] [Related]
6. The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs.
Ramerstorfer J; Furtmüller R; Sarto-Jackson I; Varagic Z; Sieghart W; Ernst M
J Neurosci; 2011 Jan; 31(3):870-7. PubMed ID: 21248110
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of GABAA receptors containing gamma1 subunits.
Khom S; Baburin I; Timin EN; Hohaus A; Sieghart W; Hering S
Mol Pharmacol; 2006 Feb; 69(2):640-9. PubMed ID: 16272224
[TBL] [Abstract][Full Text] [Related]
8. Unexpected Properties of δ-Containing GABAA Receptors in Response to Ligands Interacting with the α+ β- Site.
Mirheydari P; Ramerstorfer J; Varagic Z; Scholze P; Wimmer L; Mihovilovic MM; Sieghart W; Ernst M
Neurochem Res; 2014 Jun; 39(6):1057-1067. PubMed ID: 24072672
[TBL] [Abstract][Full Text] [Related]
9. The Differential Effects of Resveratrol and trans-ε-Viniferin on the GABA-Induced Current in GABAA Receptor Subtypes Expressed in Xenopus Laevis Oocytes.
Groundwater PW; Hamid K; Ng I; Tallapragada VJ; Hibbs DE; Hanrahan J
J Pharm Pharm Sci; 2015; 18(4):328-38. PubMed ID: 26626239
[TBL] [Abstract][Full Text] [Related]
10. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
11. Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination.
Thompson SA; Whiting PJ; Wafford KA
Br J Pharmacol; 1996 Feb; 117(3):521-527. PubMed ID: 8821543
[TBL] [Abstract][Full Text] [Related]
12. A Benzodiazepine Ligand with Improved GABA
Simeone X; Koniuszewski F; Müllegger M; Smetka A; Steudle F; Puthenkalam R; Ernst M; Scholze P
Mol Pharmacol; 2021 Jan; 99(1):39-48. PubMed ID: 33268553
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
14. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
15. Positive modulation of synaptic and extrasynaptic GABAA receptors by an antagonist of the high affinity benzodiazepine binding site.
Middendorp SJ; Maldifassi MC; Baur R; Sigel E
Neuropharmacology; 2015 Aug; 95():459-67. PubMed ID: 25963418
[TBL] [Abstract][Full Text] [Related]
16. GABA(A) receptor subtype-selectivity of novel bicuculline derivatives.
Ramerstorfer J; Foppa V; Thiery H; Hermange P; Janody S; Berger ML; Dodd RH; Sieghart W
Curr Med Chem; 2015; 22(6):771-80. PubMed ID: 25386826
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of GABAA receptors via multiple drug-binding sites.
Sieghart W
Adv Pharmacol; 2015; 72():53-96. PubMed ID: 25600367
[TBL] [Abstract][Full Text] [Related]
18. Molecular tools for GABA
Simeone X; Siebert DCB; Bampali K; Varagic Z; Treven M; Rehman S; Pyszkowski J; Holzinger R; Steudle F; Scholze P; Mihovilovic MD; Schnürch M; Ernst M
Sci Rep; 2017 Jul; 7(1):5674. PubMed ID: 28720884
[TBL] [Abstract][Full Text] [Related]
19. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug.
Sinkkonen ST; Mansikkamäki S; Möykkynen T; Lüddens H; Uusi-Oukari M; Korpi ER
Mol Pharmacol; 2003 Sep; 64(3):753-63. PubMed ID: 12920213
[TBL] [Abstract][Full Text] [Related]
20. Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes.
Ranna M; Sinkkonen ST; Möykkynen T; Uusi-Oukari M; Korpi ER
BMC Pharmacol; 2006 Jan; 6():1. PubMed ID: 16412217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
